Sinopep-Allsino Biopharmaceutical Co., Ltd. is a leading worldwide commercial API supplier and full-service CDMO, delivering large-scale GMP manufacturing for peptides, oligonucleotides, and small molecules to support global biopharma partners from development through commercial supply. We provide established peptide capacity of 20–30 metric tons annually, proven commercial-scale production for small molecule generics and NCEs, and our new large-scale GMP oligonucleotide facility in Jiangsu Lianyungang capable of thousands of kilograms per year—including ASOs, siRNA, and advanced conjugates (GalNAc, AOCs, lipid-based, POCs). With FDA-inspected facilities, strong regulatory expertise, and seamless end-to-end capabilities, Sinopep ensures reliable, high-quality, and cost-effective commercial API supply for innovative therapeutics worldwide.